Although the Cell Therapy industry is a fast-growing industry, its companies operate at a loss due to the high costs associated with research and development. Demand for the industry's products and services depends primarily on the level of investment in medical technology. Strong revenue growth is expected to slow slightly over the five years to 2022, but will still outpace the economy as a whole.
This industry engineers human tissue, also known as cell therapy or regenerative medicine. Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and chemical factors to improve or replace biological functions. Key functions include repairing or replacing tissues (e.g. bone, cartilage, blood vessels and skin).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.